TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
OKYO

OKYO Pharma Ltd

Healthcare · Biotechnology

1.40$ -1.4% vs. previous close Closing price · As of: Nov 12, 2026

Statements

Income Statement

OKYO Pharma Ltd (OKYO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Cost of Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement OKYO
Line item Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q2 26
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.0 0.0 4.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.9
0.0 – – – – – – – – – – –
0.0 0.0 8.7 0.0 0.0 0.0 3.0 0.0 4.2 4.2 2.8 6.4
0.0 0.0 -8.7 0.0 0.0 0.0 -3.0 0.0 -4.2 -4.2 -2.8 -6.4
0.0 – – – 0.0 – 0.8 – 0.1 0.1 0.1 0.4
0.0 0.0 -8.7 0.0 0.0 0.0 -4.1 0.0 -3.9 -3.9 -2.6 -6.4
0.0 0.0 0.1 0.0 0.0 0.0 -1.4 0.0 -1.8 -1.8 0.0 0.0
0.0 0.0 -8.8 0.0 0.0 0.0 -2.7 0.0 -2.0 -2.0 -2.6 -6.4
0.0 0.0 -8.7 0.0 0.0 0.0 -2.7 0.0 -3.8 -3.8 -2.8 -6.4

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?